A retrospective cohort study by Louis Poncet‐Megemont et al. revealed a high incidence of new headache onsets during the COVID-19 infection in French patients.

As already known, people with viral infections usually suffer from headaches. Remarkably, early Chinese studies described a comparatively low prevalence (12‐15%) of headaches linked with Covid‐19.

This study included laboratory-verified or chest‐CT‐confirmed Covid‐19 infection patients identified between February and April 2020 in a dedicated laboratory of Clermont‐Ferrand University Hospital. They had a follow-up for 1-month post-recovery.

On the whole, 139 consecutive patients (mean age of 48.5 years; 62.6% of women) were phone interviewed a month following withdrawal of fever and dyspnea. Generally, 59.0% of people with Covid‐19 had a mild ailment, 36.7% had a severe ailment, and 4.3% had a critical disease.

As found, 82 (59.0%) patients described new headaches through the acute phase and 3.6% had continued headaches a month following fever and dyspnea remission. 60.4% and 58.3% of the patients also frequently experienced anosmia and ageusia.

These 2 symptoms continued in 14.4% and 11.5% of Covid‐19 patients a month post-recovery. Headaches were neither evidently linked with anosmia, nor with ageusia, and were not linked with disease severity (in those requiring hospitalization or ICU).